中药靶向Wnt/β-catenin通路治疗阿尔茨海默病综述
本文综述了Wnt/β-catenin信号通路在阿尔茨海默病(AD)发病中的分子作用,以及天然化合物、中药单体和经典方剂调控该通路的神经保护证据,并讨论了血脑屏障通透性和生物利用度等挑战及未来递送策略。
要点
- Wnt/β-catenin通路与AD多个病理过程密切相关,是中药多靶点干预的潜在靶标。
- 中药可通过调控该通路抑制Aβ沉积、保护突触结构、调节细胞增殖与凋亡。
- 提高血脑屏障通透性和生物利用度是中药靶向该通路临床转化的关键挑战。
核心结论
- 中药通过调控Wnt/β-catenin信号通路发挥神经保护作用,为AD治疗提供科学依据。
研究设计与样本
- 本文为综述,系统分析Wnt/β-catenin通路与AD发病的分子互作及中药调控该通路的证据。
主要发现
- 天然化合物、中药单体和经典方剂可通过调控Wnt/β-catenin通路抑制Aβ沉积。
- 中药调控该通路可保护突触结构、调节细胞增殖与凋亡、维持代谢和氧化还原稳态。
临床怎么用
- 中药多靶点调控Wnt/β-catenin通路可能为AD提供神经保护策略。
- 未来需关注血脑屏障通透性和生物利用度,优化递送系统和给药途径。
局限性
- 提高血脑屏障通透性和增强生物利用度是当前中药靶向该通路的主要挑战。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Alzheimer's disease (AD) is a progressive neurodegenerative disorder primarily characterized by cognitive decline. Its etiology and pathogenesis are complex and multifactorial, with neurotoxicity induced by the abnormal aggregation of amyloid-beta (A[Formula: see text]) protein widely recognized as a central pathological hallmark. Current pharmacological treatments provide only limited symptomatic relief and are often associated with dose-dependent adverse effects. In contrast, Traditional Chinese Medicine (TCM) has garnered growing attention due to its distinctive therapeutic profile, and in particular, its multi-target and multi-pathway synergistic mechanisms. The Wnt/[Formula: see text]-catenin signaling pathway plays a crucial role in intracellular signal transduction and is closely associated with several key pathological processes involved in AD. This review provides a comprehensive analysis of the molecular interplay between the Wnt/[Formula: see text]-catenin signaling pathway and the pathogenesis of AD, as well as a specific focus on how natural compounds, herbal monomers, and classical TCM formulations modulate this pathway. Accumulating evidence suggests that TCM exerts neuroprotective effects by regulating Wnt/[Formula: see text]-catenin signaling to thereby suppress A[Formula: see text] deposition, preserve synaptic structure and tissue homeostasis, modulate cell proliferation and apoptosis, and maintain metabolic and redox homeostasis. Additionally, the review discusses key challenges, such as improving blood-brain barrier permeability and enhancing bioavailability, and outlines future directions involving advanced delivery systems and optimized administration routes. These insights provide a robust scientific foundation for the development of Wnt/[Formula: see text]-catenin-targeted therapies and highlight the potential of TCM in the clinical treatment of AD.
引用
- Ying C, He Y, Guo Y, et al. Application of Traditional Chinese Medicine in Alzheimer's Disease Treatment: A Focus on the Wnt/[Formula: see text]-Catenin Pathway. Am J Chin Med. 2025. PMID: 40744715. doi:10.1142/S0192415X25500624
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。